Total Nephron Number and Single-Nephron Parameters in Patients with IgA Nephropathy. Issue 5 (27th May 2021)

• Record Type: Journal Article
• Authors: Marumoto, Hirokazu; Tsuboi, Nobuo; D'Agati, Vivette D.; Sasaki, Takaya; Okabayashi, Yusuke; Haruhara, Kotaro; Kanzaki, Go; Koike, Kentaro; Shimizu, Akira; Kawamura, Tetsuya; Rule, Andrew D.; Bertram, John F.; Yokoo, Takashi
• Is Part Of: Kidney360. Volume 2:Issue 5(2021)
• Page Start: 828
• Page End: 841
• Publication Date: 2021-05-27
• Subjects: glomerular and tubulointerstitial diseases -- chronic kidney disease -- IgA nephropathy -- kidney biopsy -- proteinuria -- renal pathology; 616.61
• DOI: 10.34067/KID.0006972020
• Languages: English
• ISSNs: 2641-7650

Abstract

Visual Abstract: Abstract : Key Points: This is the first study that estimated total nephron number and related single-nephron parameters in patients with IgA nephropathy. Associations of nephron-level parameters with CKD stage and clinicopathologic findings were cross-sectionally investigated. This study illustrates the feasibility and usefulness of estimating single-nephron dynamics in human GN. Background: Single-nephron dynamics in progressive IgA nephropathy (IgAN) have not been studied. We applied novel methodology to explore single-nephron parameters in IgAN. Methods: Nonglobally sclerotic glomeruli (NSG) and globally sclerotic glomeruli (GSG) per kidney were estimated using cortical volume assessment via unenhanced computed tomography and biopsy-based stereology. Estimated single-nephron GFR (eSNGFR) and single-nephron urine protein excretion (SNUPE) were calculated by dividing eGFR and UPE by the number of NSG. Associations with CKD stage and clinicopathologic findings were cross-sectionally investigated. Results: This study included 245 patients with IgAN (mean age 43 years, 62% male, 45% on renin-angiotensin aldosterone system [RAAS] inhibitors prebiopsy) evaluated at kidney biopsy. CKD stages were 10% CKD1, 43% CKD2, 19% CKD3a, 14% CKD3b, and 14% CKD4–5. With advancing CKD stage, NSG decreased from mean 992, 000 to 300, 000 per kidney, whereas GSG increased from median 64, 000 to 202, 000 per kidney. In multivariable models, advancing CKD stage associated with lower numbers of NSG, higher numbers of GSG, and lower numbers of GSG + NSG, indicating potential resorption of sclerosed glomeruli. In contrast to the higher mean glomerular volume and markedly elevated SNUPE in advanced CKD, the eSNGFR was largely unaffected by CKD stage. Lower SNGFR associated with Oxford scores for endocapillary hypercellularity and crescents, whereas higher SNUPE associated with segmental glomerulosclerosis and tubulointerstitial scarring. Conclusions: SNUPE emerged as a sensitive biomarker of advancing IgAN. The failure of eSNGFR to increase in response to reduced number of functioning nephrons suggests limited capacity for compensatory hyperfiltration by diseased glomeruli with intrinsic lesions.